Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
Harga semasa SNN ialah $34.12 USD — telah menurun sebanyak -0.06% dalam 24 jam yang lalu. Pantau prestasi harga saham Smith & Nephew dengan lebih dekat pada carta.
Apakah simbol saham Smith & Nephew?▼
Bergantung pada bursa, simbol saham mungkin berbeza. Sebagai contoh, di bursa , saham Smith & Nephew didagangkan di bawah simbol SNN.
Adakah harga saham Smith & Nephew sedang meningkat?▼
Saham SNN meningkat sebanyak +0.92% berbanding minggu sebelumnya, perubahan bulanan ialah kenaikan +3.65%, dan sepanjang tahun lalu Smith & Nephew menunjukkan peningkatan +34.28%.
Bilakah tarikh keputusan kewangan seterusnya bagi Smith & Nephew?▼
Smith & Nephew akan mengeluarkan laporan kewangan seterusnya pada Mac 02, 2026.
Bagaimanakah keputusan kewangan Smith & Nephew pada suku lepas?▼
Keputusan kewangan SNN bagi suku terakhir ialah 0.43 USD sesaham, manakala anggaran ialah 0.4 USD, menghasilkan kejutan sebanyak +8.6%. Anggaran keputusan bagi suku berikutnya ialah Tiada USD sesaham.
Berapakah hasil Smith & Nephew untuk tahun lepas?▼
Hasil Smith & Nephew untuk tahun lalu berjumlah 5.81B USD.
Berapakah pendapatan bersih Smith & Nephew untuk tahun lepas?▼
Pendapatan bersih SNN untuk tahun lepas ialah 412M USD.
Adakah Smith & Nephew membayar dividen?▼
Ya, dividen SNN dibayar separuh tahunan. Dividen terakhir bagi setiap saham ialah 0.3 USD. Setakat hari ini, Hasil Dividen (FWD)% ialah 2.23%.
Berapa ramai pekerja yang dimiliki oleh Smith & Nephew?▼
Sehingga Februari 02, 2026, syarikat mempunyai 17,349 pekerja.
Smith & Nephew terletak dalam sektor apa?▼
Smith & Nephew beroperasi dalam sektor Health Care.
Bilakah Smith & Nephew menyiapkan split saham?▼
Pecahan saham terakhir bagi Smith & Nephew berlaku pada Oktober 15, 2014 dengan nisbah 2.5:1.
Di manakah ibu pejabat Smith & Nephew?▼
Ibu pejabat Smith & Nephew terletak di Watford, GB.